Identification of Atezolizumab Plus Bevacizumab Prognostic Index via Recursive Partitioning Analysis in HCC: The ABE Index.
Persano M, Rimini M, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Presa J, Masi G, Yoo C, Lonardi S, Pressiani T, Piscaglia F, Kumada T, Rimassa L, Scartozzi M, Cascinu S, Casadei-Gardini A; HCC COLLABORATIVE GROUP.
Persano M, et al. Among authors: lonardi s.
Anticancer Res. 2023 Apr;43(4):1599-1610. doi: 10.21873/anticanres.16310.
Anticancer Res. 2023.
PMID: 36974779